BIM expression in treatment-naive cancers predicts responsiveness to kinase inhibitors. [electronic resource]
Producer: 20121121Description: 352-65 p. digitalISSN:- 2159-8290
- Animals
- Apoptosis -- drug effects
- Apoptosis Regulatory Proteins -- biosynthesis
- BH3 Interacting Domain Death Agonist Protein -- genetics
- Bcl-2-Like Protein 11
- Cell Line, Tumor
- Cohort Studies
- ErbB Receptors -- antagonists & inhibitors
- Female
- Humans
- Lung Neoplasms -- drug therapy
- Membrane Proteins -- biosynthesis
- Mice
- Mice, Nude
- Oncogenes
- Phosphatidylinositol 3-Kinases -- genetics
- Phosphoinositide-3 Kinase Inhibitors
- Protein Kinase Inhibitors -- pharmacology
- Proto-Oncogene Proteins -- biosynthesis
- Receptor, ErbB-2 -- antagonists & inhibitors
- Retrospective Studies
- Signal Transduction -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.